Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Classificação em ações #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Preço da ação
$1.11
Valor de mercado
$27.12M
Variação (1 dia)
0.00%
Variação (1 ano)
57.93%
País
KR
Negociar Dong Sung Bio Pharm.Co.,Ltd. (002210)

Categoria

Lucros da Dong Sung Bio Pharm.Co.,Ltd. (002210)
Lucros em Mar 2026 TTM: $-18.85M
De acordo com os últimos relatórios financeiros da Dong Sung Bio Pharm.Co.,Ltd., os ganhos atuais da empresa são de $-18.85M. Em 2023, a empresa teve ganhos de $-668.88K, um aumento em relação a aos ganhos de 2022, que foram de $-1.47M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Dong Sung Bio Pharm.Co.,Ltd. de 2007 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-18.85M 261.93%
2024 $-5.21M 678.53%
2023 $-668.88K -54.39%
2022 $-1.47M -60.19%
2021 $-3.68M -62.99%
2020 $-9.95M 31.12%
2019 $-7.59M 26.29%
2018 $-6.01M 1,031.31%
2017 $-531.32K -74.81%
2016 $-2.11M -433.12%
2015 $633.14K -123.13%
2014 $-2.74M -7.49%
2013 $-2.96M -187.69%
2012 $3.37M 123.65%
2011 $1.51M -133.49%
2010 $-4.50M -873.29%
2009 $582.51K -85.64%
2008 $4.06M 9.40%
2007 $3.71M 0.00%
Lucros de empresas semelhantes ou concorrentes